Cargando…
Hepatocellular Carcinoma in a Patient With Hepatic Steatosis
Hepatocellular carcinoma (HCC) has historically developed in the setting of known risk factors—chronic liver disease from viral hepatitis and cirrhosis. In the absence of a risk factor, the development of HCC was rare. However, the increasing prevalence of nonalcoholic liver disease and nonalcoholic...
Autores principales: | Romano, John, Forster, Erin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7289280/ https://www.ncbi.nlm.nih.gov/pubmed/32607378 http://dx.doi.org/10.14309/crj.0000000000000378 |
Ejemplares similares
-
Hepatocellular carcinoma in patients cured of chronic hepatitis C: Minimal steatosis
por: Rocha, Chiara, et al.
Publicado: (2023) -
Association between hepatic steatosis and the development of hepatocellular carcinoma in patients with chronic hepatitis B
por: Lee, Yun Bin, et al.
Publicado: (2019) -
Multifocal hepatic steatosis mimicking malignancy in two siblings
por: Freebody, John, et al.
Publicado: (2019) -
Multiple drugs: Hepatic steatosis: case report
Publicado: (2021) -
Hepatic steatosis secondary to capecitabine: a case report
por: Chin, Sheray N, et al.
Publicado: (2010)